Pneumologie 2002; 56(2): 103-107
DOI: 10.1055/s-2002-20088
Originalarbeit aus dem Englischen
Georg Thieme Verlag Stuttgart · New York

Induktion direkter antibakterieller Aktivität gegen Mycobacterium tuberculosis durch Toll-like-Rezeptoren

Induction of Direct Antimicrobial Activity through Mammalian Toll-like ReceptorsS.  Stenger1 , M.  Engele1 , P.  L.  Bölcskei2 , M.  Röllinghoff1 , M.  Wagner2
  • 1Institut für Klinische Mikrobiologie, Immunologie und Hygiene, Friedrich-Alexander Universität Erlangen-Nürnberg (Leiter: Prof. Dr. M. Röllinghoff);
  • 2Klinikum Nürnberg, Medizinische Klinik III - Schwerpunkt Pneumologie (Leiter: Dr. P. L. Bölcskei, Univ.-Doz. der Semmelweis Med. Univ. Budapest)
Deutsche Fassung von: Induction of direct antimicrobial activity through mammalian Toll-like receptors, Science, 2001, 291: 1544 - 1547 · Zitat nur nach dieser Originalquelle.
Further Information

Publication History

Publication Date:
13 February 2002 (online)

Zusammenfassung

Das Immunsystem des Menschen besitzt mit den Toll-like-Rezeptoren (TLR) eine ontogenetisch sehr alte Familie von Rezeptoren, über die bereits die Fruchtfliege verfügt. Sie reagieren auf Signale von mikrobiellen Liganden. In dieser Arbeit zeigen wir, dass die Aktivierung von TLR2 zu einer Eliminierung des intrazellulären Bakteriums Mycobacterium (M.) tuberculosis auch in humanen Makrophagen führt. In Mausmakrophagen führt die Aktivierung von TLR2 durch bakterielle Lipoproteine zur Induktion eines Effektormechanismus, der durch Stickoxid-Radikale vermittelt wird. In humanen Monozyten und Alveolarmakrophagen hingegen ist das Abtöten von M. tuberculosis Stickoxid-unabhängig. Daher interagieren die TLR von Säugern ähnlich wie das Toll-Protein von Drosophila mit mikrobiellen Liganden und aktivieren am Ort der Infektion antimikrobielle Effektormechanismen.

Abstract

Drosophila, the toll gene controls a powerful innate defense system against bacteria and fungi. Conserved through evolution, the mammalian innate immune system retains a family of homologous Toll-like receptors (TLRs) that are activated by microbial ligands to release cytokines that instruct the adaptive immune responses. Here we show that TLR2 activation leads to killing of intracellular Mycobacterium (M.) tuberculosis in both mouse and human macrophages. In mouse macrophages, bacterial lipoprotein activation of TLR2 leads to a nitric oxide-dependent killing of intracellular tubercle bacilli. In human monocytes and alveolar macrophages, bacterial lipoproteins similarly activated TLR2 to kill intracellular M. tuberculosis, however by an antimicrobial pathway that is nitric oxide independent. TLR2+CD14+CD68+ macrophages were detected in human lesions of tuberculous lymphadenitis within granulomas and surrounding foci of necrosis. These data provide evidence that mammalian TLRs have retained not only the structural features of Drosophila Toll that allow them to respond to microbial ligands, but also the ability directly to activate antimicrobial effector pathways at the site of infection.

Literatur

  • 1 Lemaitre B, Nicolas E, Michaut L, Reichhart J M, Hoffmann J A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults.  Cell. 1996;  86 973-983
  • 2 Lemaitre B, Reichhart J M, Hoffmann J A. Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganismus.  Proc Natl Acad Sci U S A. 1997;  94 14614-14619
  • 3 Hoffmann J A, Kafatos F C, Janeway C A, Ezekowitz R A. Phylogenetic perspectives in innate immunity.  Science. 1999;  284 1313-1318
  • 4 Medzhitov R, Preston-Hurlburt P, Janeway Jr C A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.  Nature. 1997;  388 394-397
  • 5 Kirschning C J, Wesche H, Merrill Ayres T, Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.  J Exp Med. 1998;  188 2091-2097
  • 6 Poltorak A, He X, Smirnova I, Liu M Y, Huffel C V, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TIr4 gene.  Science. 1998;  282 2085-2088
  • 7 Brightbill H D, Libraty D H, Krutzik S R, Yang R B, Belisle J T, Bleharski J R, Maitland M, Norgard M V, Plevy S E, Smale S T, Brennan P J, Bloom B R, Godowski P J, Modlin R L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.  Science. 1999;  285 732-736
  • 8 Aliprantis A O, Yang R B, Mark M R, Suggett S, Devaux B, Radolf J D, Klimpel G R, Godowski P, Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.  Science. 1999;  285 736-739
  • 9 Underhill D M, Ozinsky A, Hajjar A M, Stevens A, Wilson C B, Bassetti M, Aderem A. The toll-like receptor-2 is recruited to macrophage phagosomes and discriminates between pathogens.  Nature. 1999;  401 811-815
  • 10 Stenger S, Mazzaccaro R J, Uyemura K, Cho S, Barnes P F, Rosat J P, Sette A, Brenner M B, Porcelli S A, Bloom B R, Modlin R L. Differential effects of cytolytic T-cell subsets on intracellular infection.  Science. 1997;  276 1684-1687
  • 11 Stenger S, Hanson D A, Teitelbaum R, Dewan P, Niazi K R, Froelich C J, Ganz T, Thoma-Uszynski S, Melian A, Bogdan C, Porcelli S A, Bloom B R, Krensky A M, Modlin R L. An antimicrobial activity of cytolytic T-cells mediated by granulysin.  Science. 1998;  282 121-125
  • 12 Jullien D, Sieling P A, Uyemura K, Mar N D, Rea T H, Modlin R L. IL-15, an immunomodulator of T-cell responses in intracellular infection.  J Immunol. 1997;  158 800-806
  • 13 Chan J, Xing Y, Magliozzo R S, Bloom B R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.  J Exp Med. 1992;  175 1111-1122
  • 14 MacMicking J D, North R J, LaCourse R, Mudgett J S, Shah S K, Nathan C F. Identification of nitric oxide synthase as a protective locus against tuberculosis.  Proc Natl Acad Sci U S A. 1997;  94 5243-5248
  • 15 Vodovotz Y, Bogdan C, Paik J, Xie Q W, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.  J Exp Med. 1993;  178 605-613
  • 16 Stenger S, Solbach W, Rollinghoff M, Bogdan C. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of inferferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4.  Eur J Immunol. 1991;  21 1669-1675
  • 17 Hirsch C S, Ellner J J, Russell D G, Rich E A. Complement receptor-mediated uptake and tumor necrosis factor-alpha- mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages.  J Immunol. 1994;  152 743-753
  • 18 Engele M, Stößel E, Castiglione K, Schwerdtner N, Wagner M, Bölcskei P, Röllinghoff M, Stenger S. Induction of Tumor Necrosis Factor in Human Alveolar Macrophages as a Potential Evasion Mechanism of Virulent Mycobacterium tuberculosis.  J Immunol. 2002;  in press
  • 19 Nicholson S, Bonecini-Almeida M dG, Lapa e Silva J R, Nathan C, Xie Q W, Mumford R, Weidner J R, Calaycay J, Geng J, Boechat N. et al . Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.  J Exp Med. 1996;  183 2293-2302

PD Dr. med. S. Stenger

Institut für Klinische Mikrobiologie, Immunologie und Hygiene

Wasserturmstr. 3

91054 Erlangen

Email: steffen.stenger@mikrobio.med.uni-erlangen.de

    >